Onderneming Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Aandelen
002399
CNE100000P02
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,42 CNY | +2,17% | +5,13% | -19,69% |
Vakgebied
Aantal werknemers: 2 080
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Preparation
54,7
%
| 3 210 | 44,8 % | 2 979 | 54,7 % | -7,21% |
API
24,0
%
| 2 674 | 37,3 % | 1 308 | 24,0 % | -51,09% |
Contract Development and Manufacturing Operations
17,8
%
| 1 084 | 15,1 % | 967 | 17,8 % | -10,80% |
Others
3,5
%
| 191 | 2,7 % | 192 | 3,5 % | +0,35% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
48,0
%
| 3 730 | 52,1 % | 2 616 | 48,0 % | -29,87% |
United States
23,5
%
| 1 387 | 19,4 % | 1 278 | 23,5 % | -7,90% |
Other Countries
20,6
%
| 1 290 | 18,0 % | 1 122 | 20,6 % | -13,01% |
China
7,6
%
| 643 | 9,0 % | 412 | 7,6 % | -35,83% |
Hong Kong
0,3
%
| 103 | 1,4 % | 18 | 0,3 % | -82,43% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yu Shan
FOU | Founder | 64 | 21-04-98 |
Tan Li
FOU | Founder | 60 | 21-04-98 |
Juan Chen
DFI | Director of Finance/CFO | 49 | 21-08-23 |
Ming Jie Wu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ji Lan Su
BRD | Director/Board Member | 45 | 01-02-04 |
Wen Xuan Zhang
IRC | Investor Relations Contact | 35 | - |
Tao Han
PRN | Corporate Officer/Principal | - | - |
Feng Qi Qian
SEC | Corporate Secretary | 39 | 01-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tan Li
FOU | Founder | 60 | 21-04-98 |
Peng Huang
BRD | Director/Board Member | 75 | 22-05-23 |
Li Li
FOU | Founder | 60 | 21-04-98 |
Yu Shan
FOU | Founder | 64 | 21-04-98 |
Hai Jun Tang
BRD | Director/Board Member | 46 | 01-02-01 |
Ji Lan Su
BRD | Director/Board Member | 45 | 01-02-04 |
Ze Hui Zheng
CHM | Chairman | 54 | 16-05-14 |
Chu An Lü
BRD | Director/Board Member | 54 | 18-12-19 |
Ming Yi
BRD | Director/Board Member | 47 | 22-05-23 |
Ping Zhang
BRD | Director/Board Member | 59 | 22-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 220 094 500 | 0 | 0 | 17,01 % |
Aandeel B | 1 | 1 247 201 704 | 249 584 561 ( 20,01 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
RESVERLOGIX CORP. 31.34% | 85 286 524 | 31.34% | 3 582 034 $ |
QUEST PHARMATECH INC. 14.78% | 25 000 000 | 14.78% | 525 000 $ |
GT BIOPHARMA, INC. 6.65% | 91 860 | 6.65% | 406 940 $ |
Bedrijfsgegevens
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
21 Langshan Road Song Ping Shan
518057, Shenzhen
+
http://www.hepalink.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,69% | 1,71 mld. | |
+19,40% | 43,75 mld. | |
+27,47% | 22,06 mld. | |
+14,23% | 14,46 mld. | |
+12,55% | 13,62 mld. | |
+37,98% | 11,61 mld. | |
-9,54% | 6,9 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+9,64% | 5,32 mld. |
- Beurs
- Aandelen
- Koers 002399
- Onderneming Shenzhen Hepalink Pharmaceutical Group Co., Ltd.